论文部分内容阅读
我国长期在新药开发方面走“仿制”之路,每年能仿制30—40种国际上市专利药品,每种药的花费只相当于国外研制一个新药总投入的千分之一。直至90年代初,我国生产的97.4%的西药品种,都是“抄袭”国外的。
China has long followed the path of “imitation” in the development of new drugs. It can imitate 30 to 40 kinds of internationally-listed patented drugs each year. The cost of each drug is only equivalent to one thousandth of foreign investment in the development of a new drug. Until the early 1990s, 97.4% of western medicine varieties produced in China were “plagiarized” abroad.